Vireo Health posts cannabis revenue rise, net loss for second quarter

What’s the right revenue per square foot? What’s a realistic business outlook for cultivators? Get realistic market forecasts, state-by-state insights and benchmarks. Get the 2023 Factbook.

Vireo Health, a Minneapolis-based multistate marijuana operator, on Thursday reported revenue of $7.2 million in the second quarter, up 70% from the same period a year ago.

The net loss for the quarter, ending June 30, was approximately $1.9 million, compared with net income of $120,080 for the prior-year period.

The company recently announced it would be expanding operations into Puerto Rico.

Vireo trades on the Canadian Securities Exchange under the ticker symbol VREO and on the U.S. over-the-counter markets as VREOF.

More details about the quarterly results can be found here.

For analysis and in-depth looks at the investment trends and deals driving the cannabis industry forward, sign up for our premium subscription service, Investor Intelligence.